Efficacy and safety of up to two years of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 May 17];7(2):s144. Available from: https://skin.dermsquared.com/skin/article/view/2025